EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes

Di Zhou iD, Leyi Zhu, Shuang Li iD, Weichun Wu iD, Baiyan Zhuang iD, Jing Xu iD, Wenjing Yang, Jian He iD, Yining Wang iD, Yuhui Zhang iD, Guanshu Liu iD, Xiaoxin Sun und 6 weitere

Circulation: Cardiovascular Imaging · 2025-03 · 18 (3)

DOI: 10.1161/circimaging.124.017246 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Cardiovascular Imaging, 2025-03. Verfasst von Di Zhou und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Magnetic Resonance Imaging (D.Z., L.Z., S.L., B.Z., J.X., W.Y., J.H., Y.W., S.Z., M.L.), Fuwai Hospital and National Center for Cardiov…. Hauptthemen laut MEDLINE: Cardiomyopathy, Dilated, Death, Sudden, Cardiac, Stroke Volume, Ventricular Function, Left. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Current guidelines recommend implantable cardioverter defibrillators for the primary prevention of sudden cardiac death (SCD) in patients with dilated cardiomyopathy with left ventricular ejection fraction (LVEF)≤35%. However, its effectiveness is hindered by the inability to reliably discriminate between the risk of SCD and competing death of heart failure deterioration, thereby limiting its clinical utility. We aimed to refine the SCD risk stratification model based on cardiac magnetic resonance imaging for patients with dilated cardiomyopathy with LVEF≤35%. METHODS: A total of 1272 patients with dilated cardiomyopathy with LVEF≤35% who underwent cardiac magnetic resonance imaging were consecutively enrolled in this study. The primary end point is a composite of SCD or aborted SCD and the second end point is a composite of heart failure death and heart transplantation. RESULTS: Over a median follow-up of 86.3 months, 101 patients reached the primary end point. In the adjusted analysis, age (hazard ratio [HR], 1.02 [95% CI, 1.01–1.04]; P =0.006) years, a family history of SCD (HR, 2.00 [95% CI, 1.01–3.98]; P =0.05), NT-proBNP (N-terminal pro-B-type natriuretic peptide) (HR, 2.02 [95% CI, 1.18–3.44]; P =0.01), LVEF (per 5% HR, 0.79 [95% CI, 0.66–0.95]; P =0.01), and late gadolinium enhancement≥7.5% (HR, 4.11[95% CI, 2.72–6.21]; P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiomyopathy, DilatedDeath, Sudden, CardiacStroke VolumeVentricular Function, LeftMagnetic Resonance Imaging, CineHumansFemaleMaleRisk AssessmentMiddle AgedRisk FactorsPredictive Value of TestsPrognosisHeart TransplantationTime FactorsAgedRetrospective StudiesAdultHeart FailureDefibrillators, Implantable

Stichwörter der Autor:innen

cardiomyopathy, dilateddeath, sudden, cardiacdefibrillators, implantableheart failureheart transplantationmagnetic resonance imaging

Autor:innen und Institutionen

  • Department of Magnetic Resonance Imaging (D.Z., L.Z., S.L., B.Z., J.X., W.Y., J.H., Y.W., S.Z., M.L.), Fuwai Hospital and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union…
  • Department of Echocardiography (W.W.), Fuwai Hospital and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Key Laboratory of Cardiovascular Imaging (Cultivation), Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China (M.L., W. W., X.S).
  • Department of Heart Failure (Y.Z.), Fuwai Hospital and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Russell H. Morgan Department of Radiology and Radiological Sciences, Division of MR Research, The Johns Hopkins University School of Medicine, Baltimore, MD (G.L.).
  • Department of Nuclear Medicine (X.S.), Fuwai Hospital and National Center for Cardiovascular Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.

ORCID-Profile: Di Zhou, Shuang Li, Weichun Wu, Baiyan Zhuang, Jing Xu, Jian He, Yining Wang, Yuhui Zhang, Guanshu Liu, Qiang Zhang, Zhongzhao Teng, Andrew E Arai, Minjie Lu

Zitieren

APA

Zhou, D., Zhu, L., Li, S., Wu, W., Zhuang, B., Xu, J., Yang, W., He, J., Wang, Y., Zhang, Y., Liu, G., Sun, X., Zhang, Q., Teng, Z., Sirajuddin, A., Arai, A. E., Zhao, S., & Lu, M. (2025). Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes. Circulation: Cardiovascular Imaging, 18(3). https://doi.org/10.1161/circimaging.124.017246

Vancouver

Zhou D, Zhu L, Li S, Wu W, Zhuang B, Xu J, et al. Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes. Circulation: Cardiovascular Imaging. 2025;18(3). doi:10.1161/circimaging.124.017246

BibTeX
@article{Zhou2025,
  author = {Zhou, Di and Zhu, Leyi and Li, Shuang and Wu, Weichun and Zhuang, Baiyan and Xu, Jing and Yang, Wenjing and He, Jian and Wang, Yining and Zhang, Yuhui and Liu, Guanshu and Sun, Xiaoxin and Zhang, Qiang and Teng, Zhongzhao and Sirajuddin, Arlene and Arai, Andrew E and Zhao, Shihua and Lu, Minjie},
  title = {Prognosis and Risk Stratification in Dilated Cardiomyopathy With LVEF≤35%: Cardiac MRI Insights for Better Outcomes},
  journal = {Circulation: Cardiovascular Imaging},
  year = {2025},
  volume = {18},
  number = {3},
  doi = {10.1161/circimaging.124.017246}
}
Kostenlos starten →